Two new studies on ransomware attacks and medical devices have drawn attention to patient safety issues.
Pharmaceutical Industry
Posted inCost of Care
Medicare Releases Details of Major Drug Price Reform
Medicare’s historic plan to slow prescription drug spending is taking shape.
Posted inCost of Care
The End of Humira’s $200 Billion Drug Monopoly
What will happen when the best selling drug ever finally faces direct competition?
Posted inCost of Care
The Race to Prepare for Medicare’s New Drug Pricing Powers
Congress gave Medicare historic new powers to lower drug prices, but lawsuits, loopholes and opposition from the drug industry could undermine them.
Posted inPublic Health
America’s Chronic Drug Shortage Problem
How one hospital is scrambling to deal with a shortage of a critical drug, and the changes needed to fix chronic supply chain issues.
Posted inHealth Equity
Off Script: One Pharmacist’s COVID Woes and Wins
A pharmacist and co-owner of an independent pharmacy in Iowa shares what life is like nearly two years into the pandemic.
Posted inCost of Care
The Aducanumab Aftermath: The Industry
How is the pharmaceutical industry reacting to the FDA’s surprising approval of a controversial Alzheimer’s drug?
Posted inCost of Care
The FDA’s Pressure-Packed Alzheimer’s Drug Decision
The FDA weighs whether to approve a controversial new Alzheimer’s drug.
Posted inCost of Care
Preventing HIV Just Got A Lot Cheaper. What Took So Long?
After nearly a decade of sky-high prices, new generics have sent the price of the HIV prevention drug PrEP plummeting.
Posted inPublic Health
What’s the Best Way to Limit the Spread of COVID-19?
Brooke Nichols on research comparing the most effective non-pharmaceutical interventions to prevent the spread of COVID-19.